Cargando…

The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT(3) receptors

Scopolamine is a high affinity muscarinic antagonist that is used for the prevention of post-operative nausea and vomiting. 5-HT(3) receptor antagonists are used for the same purpose and are structurally related to scopolamine. To examine whether 5-HT(3) receptors are affected by scopolamine we exam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lochner, Martin, Thompson, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pergamon Press 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920643/ https://www.ncbi.nlm.nih.gov/pubmed/27108935 http://dx.doi.org/10.1016/j.neuropharm.2016.04.027

Ejemplares similares

Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome
por: Iihara, Hirotoshi, et al.
Publicado: (2018)

Muscarinic Receptor Agonists and Antagonists
por: Broadley, Kenneth J., et al.
Publicado: (2001)

Investigating the Unbinding of Muscarinic Antagonists from the Muscarinic 3 Receptor
por: Buigues, Pedro J., et al.
Publicado: (2023)

Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013)

Azologization of serotonin 5-HT(3) receptor antagonists
por: Rustler, Karin, et al.
Publicado: (2019)

Novel long‐acting antagonists of muscarinic ACh receptors
por: Randáková, Alena, et al.
Publicado: (2018)

On the Use of Scopolamine, Morphine and Atropine during Chloroform Anæsthesia
por: Dunn, J. J. F.
Publicado: (1913)

Muscarinic Receptors and Their Antagonists in COPD: Anti-Inflammatory and Antiremodeling Effects
por: Karakiulakis, George, et al.
Publicado: (2012)

Structure of the human M(2) muscarinic acetylcholine receptor bound to an antagonist
por: Haga, Kazuko, et al.
Publicado: (2012)

Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats
por: Fijał, Katarzyna, et al.
Publicado: (2013)

Thermal (In)stability of Atropine and Scopolamine in the GC-MS Inlet
por: Koželj, Gordana, et al.
Publicado: (2021)

Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists
por: Liu, Hongtao, et al.
Publicado: (2018)

Scopolamine Administration Modulates Muscarinic, Nicotinic and NMDA Receptor Systems
por: Falsafi, Soheil Keihan, et al.
Publicado: (2012)

Recent advances in antiemetics: new formulations of 5HT(3)-receptor antagonists
por: Gilmore, James, et al.
Publicado: (2018)

Serotonin 5-HT3 Receptor Antagonist for Treatment of Severe Diabetic Diarrhea
por: Murao, Satoshi, et al.
Publicado: (2010)

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations
por: Galvani, Francesca, et al.
Publicado: (2023)

Discovery of new muscarinic acetylcholine receptor antagonists from Scopolia tangutica
por: Du, Nana, et al.
Publicado: (2017)

Multitargeting nature of muscarinic orthosteric agonists and antagonists
por: Myslivecek, Jaromir
Publicado: (2022)

Role of 5-HT(2A) receptor antagonists in the treatment of insomnia
por: Vanover, Kimberly E, et al.
Publicado: (2010)

Effects of 5‐HT(₃) receptor antagonists on cisplatin‐induced kidney injury
por: Goda, Mitsuhiro, et al.
Publicado: (2021)

The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review
por: Calzetta, Luigino, et al.
Publicado: (2021)

5-HT3 receptor antagonists for the prevention of postoperative shivering: a meta-analysis
por: Zhou, Chengmao, et al.
Publicado: (2016)

Functional group interactions of a 5-HT(3)R antagonist
por: Venkataraman, Padmavati, et al.
Publicado: (2002)

Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor
por: Suno, Ryoji, et al.
Publicado: (2018)

Anti-dyskinetic efficacy of 5-HT3 receptor antagonist in the hemi-parkinsonian rat model
por: Aboulghasemi, Nazanin, et al.
Publicado: (2018)

Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models
por: Calzetta, Luigino, et al.
Publicado: (2022)

Nephrotoxicity Evaluation on Cisplatin Combined with 5-HT(3) Receptor Antagonists: A Retrospective Study
por: Kou, Wen, et al.
Publicado: (2018)

Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma
por: Aalbers, René, et al.
Publicado: (2017)

CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
por: Capi, Matilde, et al.
Publicado: (2021)

Distribution of cells responsive to 5-HT(6) receptor antagonist-induced hypophagia
por: Garfield, Alastair S., et al.
Publicado: (2014)

Constitutively Active 5-HT Receptors: An Explanation of How 5-HT Antagonists Inhibit Gut Motility in Species Where 5-HT is Not an Enteric Neurotransmitter?
por: Spencer, Nick J.
Publicado: (2015)

High-affinity fluorescent ligands for the 5-HT(3) receptor
por: Simonin, Jonathan, et al.
Publicado: (2012)

Serotonin (5-HT(3)) receptor antagonists for the reduction of symptoms of low anterior resection syndrome
por: Itagaki, Ryohei, et al.
Publicado: (2014)

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists.
por: de Boer-Dennert, M., et al.
Publicado: (1997)

Atropine and Scopolamine in Maize Products from the Retail Stores in the Republic of Serbia
por: Vuković, Gorica, et al.
Publicado: (2022)

Current position of 5HT(3) antagonists and the additional value of NK(1) antagonists; a new class of antiemetics
por: de Wit, R
Publicado: (2003)

Selective 5HT3 antagonists and sensory processing: a systematic review
por: Tsitsipa, Eirini, et al.
Publicado: (2022)

Identification of a Domain which Affects Kinetics and Antagonistic Potency of Clozapine at 5-HT(3) Receptors
por: Rammes, Gerhard, et al.
Publicado: (2009)

5-HT3 and 5-HT4 antagonists inhibit peristaltic contractions in guinea-pig distal colon by mechanisms independent of endogenous 5-HT
por: Sia, Tiong C., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_d7i7sflg4mid787enb02icfh0k